Displaying items by tag: department of cell developmental and integrative biology

UAB researchers have discovered that an infant’s airway — once thought to be sterile until after birth — is colonized by bacteria or bacterial DNA, which could be protective for or predict development of severe lung disease, knowledge that may offer a therapeutic target.
Results show that JAK/STAT pathway inhibitors may be a new class of therapeutic treatments for patients with Parkinson’s disease. Acting by reducing inflammation, they prevent neurodegeneration in animal models and may be an important new approach to slow progression of the disease.
A diabetes drug combined with exercise may help older adults regrow muscle, and UAB’s Center for Exercise Medicine is investigating.
UAB's strengths in clinical care and research are powering an interdisciplinary expedition into largely uncharted territory: neuroinflammatory mechanisms in Parkinson's disease.
The UAB-HudsonAlpha Center for Genomic Medicine has awarded its first pilot grants to teams of researchers from the two institutions to pursue projects in cancer and cardiac disease.
This improvement in cognition persists despite a high-glycemic-index diet, a possible risk factor for Alzheimer’s.
Page 4 of 5